Spot gold fell in the short term, just breaking through the $2,690.00/oz mark, and the latest report was $2,689.72/oz, down 0.15% in the day.Head of South Korea's senior public official crime investigation department: If the conditions are met, it will seek to arrest Yin Xiyue. The head of South Korea's senior public official crime investigation department said that if the conditions are met, the team will seek to arrest President Yin Xiyue or seek to issue an arrest warrant for him. On Wednesday, when answering questions raised by opposition lawmakers at the National Assembly meeting, Oh Dong-woon indicated that he had the intention to arrest Yin Xiyue.Pakistan KSE-100 index rose 0.5% to 109,693.20.
Date of hearing the liquidation petition of R&F Property's subsidiary. On Wednesday, the Hong Kong court postponed the date of hearing the liquidation petition to December 16th, when representatives of R&F Properties (Hong Kong) will go to court with lawyers of Seatown Holdings Private Equity Fund. Seatown Holdings is supported by Singapore Temasek Holdings.India's SENSEX30 index opened 0.07% higher at 81,568.39 points. Among the constituent stocks, ULTRATECH CEMENT opened 1% higher, Asian Coatings rose 0.74% and BAJAJ FINANCE rose 0.62%. In terms of decline, Mahengda Information Technology opened 0.44% lower, India Industrial Credit Investment Bank fell 0.33%, and HCL TECHNOLOGIES fell 0.26%.Pakistan KSE-100 index rose 0.5% to 109,693.20.
AI glasses concept stocks continued to rise, with Zhongke Lanxun, Hengxuan Technology and Mingyue Lens rising more than 12%, while Tianjian, Xingxing Technology, Yiyuan Communication, Yitong Communication and Zhuoyi Technology had previous daily limit.Yongtai Bio-product, a new open-source shareholding company, was recognized by CDE for breakthrough therapy. On December 11th, official website, China National Medical Products Administration Drug Evaluation Center (CDE), recently announced that the anti-CD19 single-chain antibody chimeric antigen receptor T cell injection (CAR-T-19 cell injection for short) developed by Yongtai Bio-B (06978.HK) was successfully included in the list of breakthrough therapy varieties by CDE, and the indication was recurrence under 25 years old/.
Strategy guide 12-13
Strategy guide 12-13
Strategy guide
12-13
Strategy guide 12-13
Strategy guide
12-13